Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/01/2010EP2223687A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2223683A1 Oral powder and granular antitumor agent
09/01/2010EP2223682A1 Stable pharmaceutical solution formulations for pressurised metered dose inhalers
09/01/2010EP2222714A2 Polysaccharide gel compositions and methods for sustained delivery of drugs
09/01/2010EP2222712A1 Polysaccharide derivatives of lipoic acid, their preparation, use as skin cosmetics and medical devices
09/01/2010EP2222690A2 Natural brassinosteroids for use for treating hyperproliferation, treating proliferative diseases and reducing adverse effects of steroid dysfunction in mammals, pharmaceutical composition and its use
09/01/2010EP2222689A1 Compounds for therapy and diagnosis
09/01/2010EP2222682A1 Imidazo-thiazole derivatives as protein kinase inhibitors
09/01/2010EP2222681A1 Efficient aspirin prodrugs
09/01/2010EP2222675A1 5-anilinoimidazopyridines and methods of use
09/01/2010EP2222674A1 Amino triazoles as pi3k inhibitors
09/01/2010EP2222673A1 Octahydroquinoli zines for antidiabetic treatment
09/01/2010EP2222672A1 3-aminosulfonyl substituted indole derivatives and methods of use thereof
09/01/2010EP2222671A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
09/01/2010EP2222670A1 Oxadiazole derivatives for use as s1p1 agonists in the treatment of autoimmune and inflammatory disorders
09/01/2010EP2222669A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
09/01/2010EP2222668A1 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
09/01/2010EP2222667A2 Novel thiophene derivatives as agonists of s1p1/edg1
09/01/2010EP2222666A1 Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof
09/01/2010EP2222665A1 Azetidines as ep2 antagonists
09/01/2010EP2222664A1 Cycloalkyloxy-and het rocycloalky- loxypyridine compounds as modulators of the histamine h3 receptor
09/01/2010EP2222661A2 Non-nucleoside reverse transcriptase inhibitors
09/01/2010EP2222653A1 Novel 4,5-dihydroisoxazoles with estrogenic activity
09/01/2010EP2222650A1 Substituted pyrazinyl amide compounds as modulators of the histamine h3 receptor
09/01/2010EP2222649A2 Novel crystalline forms
09/01/2010EP2222648A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis
09/01/2010EP2222646A1 Uracil or thymine derivative for treating hepatitis c
09/01/2010EP2222645A2 Benzimidazole derivatives and their use as fxr agonists
09/01/2010EP2222643A1 Sinomenine derivatives and processes for their synthesis
09/01/2010EP2222641A1 A new inhibitor of dd-peptidase and its use as antibiotic or anticancer drug
09/01/2010EP2222637A1 Amidine-containing compounds useful as muscarinic receptor antagonists
09/01/2010EP2222636A2 Selective androgen receptor modulators (sarms) and uses thereof
09/01/2010EP2222632A1 Compounds which potentiate the ampa receptor and uses thereof in medicine
09/01/2010EP2222631A2 Substituted phenylmethyl bicyclocarboxyamide compounds
09/01/2010EP2222624A1 Derivatives of 4-nerolidylcatechol, pharmaceutical compositions comprising them and process for producing the same
09/01/2010EP2222376A2 3-(2,2,2-trimethylhydrazinium) propionate salts for treating ischemic heart disease
09/01/2010EP2222375A1 Improved process for the manufacture of anagrelide hidrochloride monhydrate
09/01/2010EP2222326A2 Inhibitors of malt1 proteolytic activity and uses thereof
09/01/2010EP2222319A2 Topical drugs for use in antifungal therapy
09/01/2010EP2222313A1 Pharmaceutical compositions
09/01/2010EP2222312A1 Aqueous iron dextran preparation having one or more para-hydroxybenzoate compounds and/or salts thereof
09/01/2010EP2222309A1 Antibiotic macrocycle compounds and methods of manufacture and use thereof
09/01/2010EP2222308A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
09/01/2010EP2222307A1 Use of amorolfine for treating a nail disease by iontophoresis
09/01/2010EP2222305A1 Methods for reducing blood pressure
09/01/2010EP2222304A2 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
09/01/2010EP2222303A1 A method for treating addiction
09/01/2010EP2222302A1 A method for treating over-eating disorders
09/01/2010EP2222301A1 Method and composition for treating an alpha adrenoceptor-mediated condition
09/01/2010EP2222300A1 Method and composition for treating a serotonin receptor-mediated condition
09/01/2010EP2222299A2 Use of levocabastine for modulating generation of pro-inflammatory cytokines
09/01/2010EP2222298A1 Use of cfms inhibitor for treating or preventing bone cancer and the bone loss and bone pain associated with bone cancer
09/01/2010EP2222295A2 Pharmaceutical composition for treatment and prevention of kidney diseases
09/01/2010EP2222293A1 Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate
09/01/2010EP2222291A2 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
09/01/2010EP2222290A1 Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders
09/01/2010EP2222289A1 Treatment of oral pharyngeal dysphagia
09/01/2010EP2222287A2 Multitarget compounds active at a ppar and cannabinoid receptor
09/01/2010EP2222278A1 Improved taxane delivery system
09/01/2010EP2222276A1 Stable elsamitrucin salt formulations
09/01/2010EP2222273A2 Liquid compositions comprising valsartan
09/01/2010EP2222272A1 Respiratory disease treatment
09/01/2010EP2222168A1 Solvent systems for pour-on formulations for combating parasites
09/01/2010EP2222167A2 Methods and compositions for inhibiting integrins using tellurium-containing compounds
09/01/2010EP2222166A1 Heterocyclic kinase inhibitors
09/01/2010EP2222160A2 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
09/01/2010EP2125793B1 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
09/01/2010EP2102215B1 4,5,6,7-tetrahydro-thieno [2,3-c]pyridines as h3 modulators
09/01/2010EP2057122B1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor
09/01/2010EP2022788B1 Novel crystal of 3-[5-[4-(cyclopentyloxy)-2- hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid
09/01/2010EP2019825B1 Inhibitors of human immunodeficiency virus replication
09/01/2010EP2010551B1 Improved treatment of cystic fibrosis
09/01/2010EP2004657B1 Condensed imidazole derivatives as aldosterone synthase inhibitors
09/01/2010EP2004188B1 Benzoimidazol-2-yl pyridines as modulators of the histamine h4 receptor
09/01/2010EP1998778B1 Use of (s)-roscovitine for the prevention and/or treatment of neurological disorders
09/01/2010EP1983987B1 Dihydrodiazepines useful as inhibitors of protein kinases
09/01/2010EP1979322B1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
09/01/2010EP1963337B1 THIENO[2,3-b]PYRIDINE DERIVATIVES
09/01/2010EP1928428B1 A pharmaceutical formulation containing olanzapine
09/01/2010EP1874766B1 Crystalline form of a quinolinone-carboxamide compound
09/01/2010EP1864683B1 Radiotherapy enhancer
09/01/2010EP1863803B1 Substituted piperidines
09/01/2010EP1856096B1 Phenylglycinamide derivatives useful as anticoagulants
09/01/2010EP1854787B1 Novel cyclic compound having quinolylalkylthio group
09/01/2010EP1845092B1 Pyrimidinone compounds, their preparation and use thereof
09/01/2010EP1838698B1 Pyrimidine derivatives as gpcr agonists
09/01/2010EP1814857B1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands
09/01/2010EP1812439B1 Kinase inhibitors
09/01/2010EP1751126B1 Alkyl carbamate-substituted butyrolactones serving as lipase inhibitors
09/01/2010EP1726587B1 Benzothiazin-3-one compound and intermediate therefor
09/01/2010EP1720546B1 Novel, sustained-action beta-2-agonists and their use as medicaments
09/01/2010EP1709047B1 Azabenzofuran substituted thioureas as inhibitors of viral replication
09/01/2010EP1662908B9 Composition and method for facilitating bone healing
09/01/2010EP1635839B1 Benzo[4,5]thieno[2,3-d]pyrimidin-4-ones and their use in therapy
09/01/2010EP1607394B1 Water-soluble thalidomine derivatives
09/01/2010EP1594854B1 Thiazolyl-based compounds useful as kinase inhibitors
09/01/2010EP1583525B1 Use of porphyrin synthesis substances in combination with salicylates and antioxidants for use in phototherapy to cure skin and articulation diseases
09/01/2010EP1560488B1 Antibacterial agents
09/01/2010EP1558614B1 Pyridopyrrolizine and pyridoindolizine derivatives
09/01/2010EP1469809B1 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same
1 ... 2110 2111 2112 2113 2114 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 ... 7860